Universitätsklinikum Bonn

Hospital


Location: Bonn, Germany (DE) DE

ISNI: 000000008786803X

ROR: https://ror.org/01xnwqx93

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

SD-OCT-histopathologic correlation in Schnabel’s cavernous optic nerve atrophy (2025) Weber C, Mercieca K, Weller J, Bulirsch LM, Ach T, Holz FG, Loeffler KU, Herwig-Carl MC Journal article A Radiologist’s Guide to IDH-Wildtype Glioblastoma for Efficient Communication With Clinicians: Part II–Essential Information on Post-Treatment Imaging (2025) Vollmuth P, Karschnia P, Sahm F, Park YW, Ahn SS, Jain R Journal article, Review article TFAP2E is implicated in central nervous system, orofacial and maxillofacial anomalies. (2025) Kalanithy JC, Mingardo E, Stegmann JD, Dhakar R, Dakal TC, Rosenfeld JA, Tan WH, et al. Journal article Trio Exome Sequencing in VACTERL Association (2025) Ćomić J, Tilch E, Riedhammer KM, Brugger M, Brunet T, Eyring K, Vill K, et al. Journal article Idecabtagene vicleucel or ciltacabtagene autoleucel for relapsed or refractory multiple myeloma: An international multicenter study (2025) Merz M, Albici AM, von Tresckow B, Rathje K, Fenk R, Holderried T, Müller F, et al. Journal article Psychological and Social Factors Associated With Reporting Post-COVID Symptoms Among German Healthcare Workers: A Cross-Sectional Study (2025) Schick V, Lieb M, Borho A, Morawa E, Geiser F, Beschoner P, Jerg-Bretzke L, et al. Journal article The modified Glasgow Prognostic Score (mGPS) can guide decisions for immunotherapy treatment beyond progression. (2025) Saal J, Eckstein M, Ritter M, Brossart P, Hölzel M, Grünwald V, Klümper N Journal article Treatment of Advanced or Metastatic Urothelial Cancer (2025) Hilser T, Darr C, Bedke J, Ivanyi P, Klümper N, Eckstein M, Schlack K, Grünwald V Journal article, Review article Group 2 innate lymphoid cells are a non-redundant source of interleukin-5 required for development and function of murine B1 cells (2024) Troch KF, Jakob MO, Forster PM, Jarick KJ, Schreiber J, Preusser A, Guerra GM, et al. Journal article Bispecific antibodies targeting BCMA or GPRC5D are highly effective in relapsed myeloma after CAR T-cell therapy (2024) Merz M, Dima D, Hashmi H, Ahmed N, Stölzel F, Holderried TA, Fenk R, et al. Journal article